Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery

Biomaterials

Volumn 32, Issue 26, 2011, Pages 6302-6315

  Tagalakis, Aristides D ^a   He, Lin ^a   Saraiva, Luisa ^a   Gustafsson, Kenth T ^a   Hart, Stephen L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Gene silencing; Liposomes; Nanoparticle; RNA interference; SiRNA delivery; Targeting

Indexed keywords

CATIONIC LIPIDS; CELL LINES; FURTHER DEVELOPMENT; GENE KNOCK DOWN; GENE SILENCING; HEPARIN TREATMENT; HUMAN AIRWAY; IN-VITRO; IN-VIVO; LIPOFECTAMINE; NANOCOMPLEXES; NANOPARTICLE FORMULATION; NEUROBLASTOMAS; NON-TARGETED; PARTICLE STABILITY; PERINUCLEAR REGION; RNA INTERFERENCE; RNA-INDUCED SILENCING COMPLEXES; SELF-ASSEMBLE; SIRNA DELIVERY; SMALL INTERFERING RNA (SIRNA); SPHERICAL PARTICLE; TARGETING; TRANSFECTION EFFICIENCY;

CELL CULTURE; CONFOCAL MICROSCOPY; EFFICIENCY; GENES; GENETIC ENGINEERING; LIPOSOMES; MAMMALS; NANOPARTICLES; OPTIMIZATION; PEPTIDES; PHOSPHOLIPIDS; TISSUE;

RNA;

1,2 DI HEXADEC 11 ENYLOXY N,N,N TRIMETHYLAMMONIUM PROPANE IODIDE; 2,3 DIOLEYLOXYPROPYL 1 TRIMETHYLAMMONIUM CHLORIDE; ALKYL ARYL ETHER; CARBON; CATION; DITETRADECYL TRIMETHYL AMMONIA; DOUBLE STRANDED RNA; HEPARIN; LIGAND; LIPID; LIPOFECTAMINE; LIPOSOME; LUCIFERASE; NANOPARTICLE; PEPTIDE; REAGENT; RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINE; CONFOCAL MICROSCOPY; CYTOPLASM; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; INCUBATION TEMPERATURE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY EPITHELIUM; RNA INTERFERENCE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE SILENCING; HEPARIN; HUMANS; LIPOSOMES; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; MICROSCOPY, ELECTRON, TRANSMISSION; NANOCONJUGATES; PEPTIDES; RATS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

RATTUS;

EID: 79959915264     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.05.022     Document Type: Article

References (62)

1. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
2. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
3. Sibley C.R., Seow Y., Wood M.J. Novel RNA-based strategies for therapeutic gene silencing. Mol Ther 2010, 18:466-476.
4. Jagannath A., Wood M.J. Localization of double-stranded small interfering RNA to cytoplasmic processing bodies is Ago2 dependent and results in up-regulation of GW182 and Argonaute-2. Mol Biol Cell 2009, 20:521-529.
5. Gregory R.I., Chendrimada T.P., Cooch N., Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005, 123:631-640.
6. Rand T.A., Petersen S., Du F., Wang X. Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell 2005, 123:621-629.
7. Dykxhoorn D.M., Lieberman J. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs. Annu Rev Biomed Eng 2006, 8:377-402.
8. Xie F.Y., Woodle M.C., Lu P.Y. Harnessing in vivo siRNA delivery for drug discovery and therapeutic development. Drug Discov Today 2006, 11:67-73.
9. Wagstaff K.M., Jans D.A. Nucleocytoplasmic transport of DNA: enhancing non-viral gene transfer. Biochem J 2007, 406:185-202.
10. Jeong J.H., Park T.G., Kim S.H. Self-assembled and nanostructured siRNA delivery systems. Pharm Res 2011, [Epub ahead of print].
11. de Fougerolles A., Vornlocher H.P., Maraganore J., Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 2007, 6:443-453.
12. Tagalakis A.D., Grosse S.M., Meng Q.H., Mustapa M.F., Kwok A., Salehi S.E., et al. Integrin-targeted nanocomplexes for tumour specific delivery and therapy by systemic administration. Biomaterials 2011, 32:1370-1376.
13. Grosse S.M., Tagalakis A.D., Mustapa M.F., Elbs M., Meng Q.H., Mohammadi A., et al. Tumor-specific gene transfer with receptor-mediated nanocomplexes modified by polyethylene glycol shielding and endosomally cleavable lipid and peptide linkers. FASEB J 2010, 24:2301-2313.
14. Tagalakis A.D., McAnulty R.J., Devaney J., Bottoms S.E., Wong J.B., Elbs M., et al. A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer. Mol Ther 2008, 16:907-915.
15. Irvine S.A., Meng Q.H., Afzal F., Ho J., Wong J.B., Hailes H.C., et al. Receptor-targeted nanocomplexes optimized for gene transfer to primary vascular cells and explant cultures of rabbit aorta. Mol Ther 2008, 16:508-515.
16. Meng Q.H., Jamal W., Hart S.L., McEwan J.R. Application to vascular adventitia of a nonviral vector for TIMP-1 gene therapy to prevent intimal hyperplasia. Hum Gene Ther 2006, 17:717-727.
17. Jenkins R.G., Meng Q.H., Hodges R.J., Lee L.K., Bottoms S.E., Laurent G.J., et al. Formation of LID vector complexes in water alters physicochemical properties and enhances pulmonary gene expression in vivo. Gene Ther 2003, 10:1026-1034.
18. Cunningham S., Meng Q.H., Klein N., McAnulty R.J., Hart S.L. Evaluation of a porcine model for pulmonary gene transfer using a novel synthetic vector. J Gene Med 2002, 4:438-446.
19. Kwok A., Hart S.L. Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA delivery. Nanomedicine 2011, 7:210-219.
20. Writer M.J., Marshall B., Pilkington-Miksa M.A., Barker S.E., Jacobsen M., Kritz A., et al. Targeted gene delivery to human airway epithelial cells with synthetic vectors incorporating novel targeting peptides selected by phage display. J Drug Target 2004, 12:185-193.
21. Bainbridge J.W., Smith A.J., Barker S.S., Robbie S., Henderson R., Balaggan K., et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008, 358:2231-2239.
22. Cartier N., Hacein-Bey-Abina S., Bartholomae C.C., Veres G., Schmidt M., Kutschera I., et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009, 326:818-823.
23. Davis M.E., Zuckerman J.E., Choi C.H., Seligson D., Tolcher A., Alabi C.A., et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010, 464:1067-1070.
24. Ebbesen M., Jensen T.G., Andersen S., Pedersen F.S. Ethical perspectives on RNA interference therapeutics. Int J Med Sci 2008, 5:159-168.
25. Morgan R.A., Dudley M.E., Wunderlich J.R., Hughes M.S., Yang J.C., Sherry R.M., et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006, 314:126-129.
26. Ott M.G., Schmidt M., Schwarzwaelder K., Stein S., Siler U., Koehl U., et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006, 12:401-409.
27. Grayson A.C., Doody A.M., Putnam D. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm Res 2006, 23:1868-1876.
28. Merkel O.M., Librizzi D., Pfestroff A., Schurrat T., Buyens K., Sanders N.N., et al. Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by fluorescence fluctuation spectroscopy and single photon emission computed tomography (SPECT) imaging. J Control Release 2009, 138:148-159.
29. El-Sayed A., Khalil I.A., Kogure K., Futaki S., Harashima H. Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape. J Biol Chem 2008, 283:23450-23461.
30. Kumar P., Wu H., McBride J.L., Jung K.E., Kim M.H., Davidson B.L., et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007, 448:39-43.
31. Patil M.L., Zhang M., Betigeri S., Taratula O., He H., Minko T. Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery. Bioconjug Chem 2008, 19:1396-1403.
32. Katas H., Alpar H.O. Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release 2006, 115:216-225.
33. Howard K.A., Rahbek U.L., Liu X., Damgaard C.K., Glud S.Z., Andersen M.O., et al. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol Ther 2006, 14:476-484.
34. Gao H., Shi W., Freund L.B. Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci U S A 2005, 102:9469-9474.
35. Aoki H., Satoh M., Mitsuzuka K., Ito A., Saito S., Funato T., et al. Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of beta 1,4GalNAc transferase. FEBS Lett 2004, 567:203-208.
36. Hart S.L., Arancibia-Carcamo C.V., Wolfert M.A., Mailhos C., O'Reilly N.J., Ali R.R., et al. Lipid-mediated enhancement of transfection by a nonviral integrin- targeting vector. Hum Gene Ther 1998, 9:575-585.
37. Meng Q.H., Robinson D., Jenkins R.G., McAnulty R.J., Hart S.L. Efficient transfection of non-proliferating human airway epithelial cells with a synthetic vector system. J Gene Med 2004, 6:210-221.
38. Parkes R., Meng Q.H., Elena Siapati K., McEwan J.R., Hart S.L. High efficiency transfection of porcine vascular cells in vitro with a synthetic vector system. J Gene Med 2002, 4:292-299.
39. Uduehi A., Mailhos C., Truman H., Thrasher A.J., Kinnon C., Hart S.L. Enhancement of integrin-mediated transfection of haematopoietic cells with a synthetic vector system. Biotechnol Appl Biochem 2003, 38:201-209.
40. White R.E., Wade-Martins R., Hart S.L., Frampton J., Huey B., Desai-Mehta A., et al. Functional delivery of large genomic DNA to human cells with a peptide-lipid vector. J Gene Med 2003, 5:883-892.
41. Writer M., Hurley C.A., Sarkar S., Copeman D.M., Wong J.B., Odlyha M., et al. Analysis and optimization of the cationic lipid component of a lipid/peptide vector formulation for enhanced transfection in vitro and in vivo. J Liposome Res 2006, 16:373-389.
42. Jenkins R.G., Herrick S.E., Meng Q.H., Kinnon C., Laurent G.J., McAnulty R.J., et al. An integrin-targeted non-viral vector for pulmonary gene therapy. Gene Ther 2000, 7:393-400.
43. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 1987, 84:7413-7417.
44. Hagerman P.J. Flexibility of RNA. Annu Rev Biophys Biomol Struct 1997, 26:139-156.
45. Kebbekus P., Draper D.E., Hagerman P. Persistence length of RNA. Biochemistry 1995, 34:4354-4357.
46. Grayson S.M., Godbey W.T. The role of macromolecular architecture in passively targeted polymeric carriers for drug and gene delivery. J Drug Target 2008, 16:329-356.
47. Corsi K., Chellat F., Yahia L., Fernandes J.C. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials 2003, 24:1255-1264.
48. Jere D., Yoo M.K., Arote R., Kim T.H., Cho M.H., Nah J.W., et al. Poly (amino ester) composed of poly (ethylene glycol) and aminosilane prepared by combinatorial chemistry as a gene carrier. Pharm Res 2008, 25:875-885.
49. Farhood H., Serbina N., Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. BBA 1995, 1235:289-295.
50. Xu Y., Szoka F.C. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 1996, 35:5616-5623.
51. Schaffer D.V., Fidelman N.A., Dan N., Lauffenburger D.A. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol Bioeng 2000, 67:598-606.
52. Mannisto M., Reinisalo M., Ruponen M., Honkakoski P., Tammi M., Urtti A. Polyplex-mediated gene transfer and cell cycle: effect of carrier on cellular uptake and intracellular kinetics, and significance of glycosaminoglycans. J Gene Med 2007, 9:479-487.
53. Erbacher P., Roche A.C., Monsigny M., Midoux P. The reduction of the positive charges of polylysine by partial gluconoylation increases the transfection efficiency of polylysine/DNA complexes. Biochim Biophys Acta 1997, 1324:27-36.
54. Bolcato-Bellemin A.L., Bonnet M.E., Creusat G., Erbacher P., Behr J.P. Sticky overhangs enhance siRNA-mediated gene silencing. Proc Natl Acad Sci U S A 2007, 104:16050-16055.
55. Chen T.H., Bae Y., Furgeson D.Y. Intelligent biosynthetic nanobiomaterials (IBNs) for hyperthermic gene delivery. Pharm Res 2008, 25:683-691.
56. Neu M., Sitterberg J., Bakowsky U., Kissel T. Stabilized nanocarriers for plasmids based upon cross-linked poly(ethylene imine). Biomacromolecules 2006, 7:3428-3438.
57. Sundaram S., Viriyayuthakorn S., Roth C.M. Oligonucleotide structure influences the interactions between cationic polymers and oligonucleotides. Biomacromolecules 2005, 6:2961-2968.
58. Nguyen J., Steele T.W., Merkel O., Reul R., Kissel T. Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy. J Control Release 2008, 132:243-251.
59. Haupenthal J., Baehr C., Kiermayer S., Zeuzem S., Piiper A. Inhibition of RNAse A family enzymes prevents degradation and loss of silencing activity of siRNAs in serum. Biochem Pharmacol 2006, 71:702-710.
60. Griesenbach U., Kitson C., Escudero Garcia S., Farley R., Singh C., Somerton L., et al. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. Respir Res 2006, 7:26. doi:10.1186/1465-9921-7-26.
61. Ofek P., Fischer W., Calderon M., Haag R., Satchi-Fainaro R. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers. FASEB J 2010, 24:3122-3134.
62. Portis A.M., Carballo G., Baker G.L., Chan C., Walton S.P. Confocal microscopy for the analysis of siRNA delivery by polymeric nanoparticles. Microsc Res Tech 2010, 73:878-885.